ArticleFoods (Basel, Switzerland)2026
Gelatin Improve Storage Stability of Alginate-Encapsuled Krill Oil Microcapsules.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Antarctic krill oil (AKO) is a valuable nutraceutical; however, it is highly susceptible to oxidation. Encapsulation represents an effective strategy to enhance the storage stability of AKO. This study explored a novel approach for encapsulating AKO using sodium alginate (ALG) and gelatin (GLN) to improve its stability, and multiple parameters were systematically evaluated, including oil-loading efficiency, surface oil content, particle size, water activity, and thermal stability. Additionally, core-material retention efficiency, acid value, peroxide value, and anisidine value were measured after accelerated oxidation. The results demonstrated that the optimal encapsulation conditions consisted of an ALG:GLN ratio of 2:1, a 9% CaCl
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.